Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:56:00.877Z.
Calculation as of: 2026-10-06T14:56:00.877Z.
Quote observation: 2026-10-06T14:50:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Baird Medical Investment Holdings Limited
Market Cap
$31.36M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.44M
EV/EBIT Ratio
19.06x
TTM Avg
29.28x
3Y Avg
15.24x
5Y Avg
15.09x
Market Cap
$32.76M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baird Medical Investment Holdings Limited (BDMD) | $31.36M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.36M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 19.06x | 29.28x | 15.24x | 15.09x |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.86M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.70M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.28M | N/A | 0.37x | 0.82x | 0.82x |
| GridAI Technologies Corp. (GRDX)vs › | $30.02M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.04M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
